Refractory systemic lupus erythematosus with neuropsychiatric manifestations successfully treated with anifrolumab

Scand J Rheumatol. 2024 May;53(3):226-228. doi: 10.1080/03009742.2024.2306053. Epub 2024 Jan 26.

Authors

Y Kobayashi¹, S Hanai¹, T Iwamoto², D Nakagomi¹

Affiliations

¹ Department of Rheumatology, University of Yamanashi Hospital, Yamanashi, Japan.
² Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan.

PMID: 38275190
DOI: 10.1080/03009742.2024.2306053

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Lupus Erythematosus, Systemic* / complications
Lupus Erythematosus, Systemic* / drug therapy

Substances

anifrolumab
Antibodies, Monoclonal, Humanized